-
1
-
-
0031010050
-
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member
-
McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 387:1997;83-90.
-
(1997)
Nature
, vol.387
, pp. 83-90
-
-
McPherron, A.C.1
Lawler, A.M.2
Lee, S.J.3
-
2
-
-
13044265837
-
Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting
-
Gonzalez-Cadavid N.F., Taylor W.E., Yarasheski K., Sinha-Hikim I., Ma K., Ezzat S., Shen R., Lalani R., Asa S., Mamita M., Nair G., Arver S., Bhasin S. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc. Natl. Acad. Sci. USA. 95:1998;14938-14943.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 14938-14943
-
-
Gonzalez-Cadavid, N.F.1
Taylor, W.E.2
Yarasheski, K.3
Sinha-Hikim, I.4
Ma, K.5
Ezzat, S.6
Shen, R.7
Lalani, R.8
Asa, S.9
Mamita, M.10
Nair, G.11
Arver, S.12
Bhasin, S.13
-
3
-
-
0034785955
-
The two myostatin genes of Atlantic salmon (Salmo salar) are expressed in a variety of tissues
-
Ostbye T.K., Galloway T.F., Nielsen C., Gabestad I., Bardal T., Andersen O. The two myostatin genes of Atlantic salmon (Salmo salar) are expressed in a variety of tissues. Eur. J. Biochem. 268:2001;5249-5257.
-
(2001)
Eur. J. Biochem.
, vol.268
, pp. 5249-5257
-
-
Ostbye, T.K.1
Galloway, T.F.2
Nielsen, C.3
Gabestad, I.4
Bardal, T.5
Andersen, O.6
-
4
-
-
33746845652
-
Myostatin expression in porcine tissues: Tissue specificity and developmental and postnatal regulation
-
Ji S., Losinski R.L., Cornelius S.G., Frank G.R., Willis G.M., Gerrard D.E., Depreux F.F., Spurlock M.E. Myostatin expression in porcine tissues tissue specificity and developmental and postnatal regulation . Am. J. Physiol. 275:1998;R1265-1273.
-
(1998)
Am. J. Physiol.
, vol.275
, pp. 1265-1273
-
-
Ji, S.1
Losinski, R.L.2
Cornelius, S.G.3
Frank, G.R.4
Willis, G.M.5
Gerrard, D.E.6
Depreux, F.F.7
Spurlock, M.E.8
-
5
-
-
16944364045
-
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle
-
Grobet L., Martin L.J., Poncelet D., Pirottin D., Brouwers B., Riquet J., Schoeberlein A., Dunner S., Menissier F., Massabanda J., Fries R., Hanset R., Georges M. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nature Genet. 17:1997;71-74.
-
(1997)
Nature Genet.
, vol.17
, pp. 71-74
-
-
Grobet, L.1
Martin, L.J.2
Poncelet, D.3
Pirottin, D.4
Brouwers, B.5
Riquet, J.6
Schoeberlein, A.7
Dunner, S.8
Menissier, F.9
Massabanda, J.10
Fries, R.11
Hanset, R.12
Georges, M.13
-
6
-
-
0030818314
-
Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle
-
Kambadur R., Sharma M., Smith T.P., Bass J.J. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res. 7:1997;910-916.
-
(1997)
Genome Res.
, vol.7
, pp. 910-916
-
-
Kambadur, R.1
Sharma, M.2
Smith, T.P.3
Bass, J.J.4
-
7
-
-
0030840359
-
Double muscling in cattle due to mutations in the myostatin gene
-
McPherron A.C., Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA. 94:1997;12457-12461.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 12457-12461
-
-
McPherron, A.C.1
Lee, S.J.2
-
8
-
-
0033971745
-
Modulation of myostatin expression during modified muscle use
-
Wehling M., Cai B., Tidball J.G. Modulation of myostatin expression during modified muscle use. FASEB J. 14:2000;103-110.
-
(2000)
FASEB J.
, vol.14
, pp. 103-110
-
-
Wehling, M.1
Cai, B.2
Tidball, J.G.3
-
9
-
-
0032832616
-
Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading
-
Carlson C.J., Booth F.W., Gordon S.E. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am. J. Physiol. 277:1999;R601-606.
-
(1999)
Am. J. Physiol.
, vol.277
, pp. 601-606
-
-
Carlson, C.J.1
Booth, F.W.2
Gordon, S.E.3
-
10
-
-
0033006969
-
Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct
-
Sharma M., Kambadur R., Matthews K.G., Somers W.G., Devlin G.P., Conaglen J.V., Fowke P.J., Bass J.J. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J. Cell. Physiol. 180:1999;1-9.
-
(1999)
J. Cell. Physiol.
, vol.180
, pp. 1-9
-
-
Sharma, M.1
Kambadur, R.2
Matthews, K.G.3
Somers, W.G.4
Devlin, G.P.5
Conaglen, J.V.6
Fowke, P.J.7
Bass, J.J.8
-
11
-
-
0017759258
-
Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
-
Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 270:1977;725-727.
-
(1977)
Nature
, vol.270
, pp. 725-727
-
-
Yaffe, D.1
Saxel, O.2
-
12
-
-
0034704106
-
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation
-
Thomas M., Langley B., Berry C., Sharma M., Kirk S., Bass J., Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J. Biol. Chem. 275:2000;40235-40243.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 40235-40243
-
-
Thomas, M.1
Langley, B.2
Berry, C.3
Sharma, M.4
Kirk, S.5
Bass, J.6
Kambadur, R.7
-
13
-
-
0035010607
-
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells
-
Taylor W.E., Bhasin S., Artaza J., Byhower F., Azam M., Willard D.H. Jr., Kull F.C. Jr., Gonzalez-Cadavid N. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 280:2001;E221-228.
-
(2001)
Am. J. Physiol. Endocrinol. Metab.
, vol.280
, pp. 221-228
-
-
Taylor, W.E.1
Bhasin, S.2
Artaza, J.3
Byhower, F.4
Azam, M.5
Willard D.H., Jr.6
Kull F.C., Jr.7
Gonzalez-Cadavid, N.8
-
16
-
-
0037147210
-
Myostatin inhibits myoblast differentiation by down-regulating MyoD expression
-
Langley B., Thomas M., Bishop A., Sharma M., Gilmour S., Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 277:2002;49831-49840.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 49831-49840
-
-
Langley, B.1
Thomas, M.2
Bishop, A.3
Sharma, M.4
Gilmour, S.5
Kambadur, R.6
-
17
-
-
0027499060
-
Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
-
Gu W., Schneider J.W., Condorelli G., Kaushal S., Mahdavi V., Nadal-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 72:1993;309-324.
-
(1993)
Cell
, vol.72
, pp. 309-324
-
-
Gu, W.1
Schneider, J.W.2
Condorelli, G.3
Kaushal, S.4
Mahdavi, V.5
Nadal-Ginard, B.6
-
18
-
-
0028980494
-
P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts
-
Agarwal M.L., Agarwal A., Taylor W.R., Stark G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA. 92:1995;8493-8497.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 8493-8497
-
-
Agarwal, M.L.1
Agarwal, A.2
Taylor, W.R.3
Stark, G.R.4
-
19
-
-
0028813528
-
Evidence for a second cell cycle block at G2/M by p53
-
Stewart N., Hicks G.G., Paraskevas F., Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene. 10:1995;109-115.
-
(1995)
Oncogene
, vol.10
, pp. 109-115
-
-
Stewart, N.1
Hicks, G.G.2
Paraskevas, F.3
Mowat, M.4
-
20
-
-
0035979253
-
Regulation of myostatin activity and muscle growth
-
Lee S.J., McPherron A.C. Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. USA. 98:2001;9306-9311.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 9306-9311
-
-
Lee, S.J.1
McPherron, A.C.2
-
21
-
-
0035810054
-
Regulation of the G2/M transition by p53
-
Taylor W.R., Stark G.R. Regulation of the G2/M transition by p53. Oncogene. 20:2001;1803-1815.
-
(2001)
Oncogene
, vol.20
, pp. 1803-1815
-
-
Taylor, W.R.1
Stark, G.R.2
-
22
-
-
0029996726
-
Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation
-
Wang J., Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science. 273:1996;359-361.
-
(1996)
Science
, vol.273
, pp. 359-361
-
-
Wang, J.1
Walsh, K.2
-
23
-
-
0031810964
-
Phosphorylation of nuclear MyoD is required for its rapid degradation
-
Song A., Wang Q., Goebl M.G., Harrington M.A. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol. Cell. Biol. 18:1998;4994-4999.
-
(1998)
Mol. Cell. Biol.
, vol.18
, pp. 4994-4999
-
-
Song, A.1
Wang, Q.2
Goebl, M.G.3
Harrington, M.A.4
-
24
-
-
0032935671
-
Cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: Role in modulating MyoD half-life and myogenic activity
-
Kitzmann M., Vandromme M., Schaeffer V., Carnac G., Labbe J.C., Lamb N., Fernandez A. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts role in modulating MyoD half-life and myogenic activity . Mol. Cell. Biol. 19:1999;3167-3176.
-
(1999)
Mol. Cell. Biol.
, vol.19
, pp. 3167-3176
-
-
Kitzmann, M.1
Vandromme, M.2
Schaeffer, V.3
Carnac, G.4
Labbe, J.C.5
Lamb, N.6
Fernandez, A.7
-
25
-
-
0032695604
-
P57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts
-
Reynaud E.G., Pelpel K., Guillier M., Leibovitch M.P., Leibovitch S.A. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts. Mol. Cell. Biol. 19:1999;7621-7629.
-
(1999)
Mol. Cell. Biol.
, vol.19
, pp. 7621-7629
-
-
Reynaud, E.G.1
Pelpel, K.2
Guillier, M.3
Leibovitch, M.P.4
Leibovitch, S.A.5
-
26
-
-
0029058587
-
Inhibition of cyclin-dependent kinases by p21
-
Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P., Dobrowolski S., Bai C., Connell-Crowley L., Swindell E., et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:1995;387-400.
-
(1995)
Mol. Biol. Cell.
, vol.6
, pp. 387-400
-
-
Harper, J.W.1
Elledge, S.J.2
Keyomarsi, K.3
Dynlacht, B.4
Tsai, L.H.5
Zhang, P.6
Dobrowolski, S.7
Bai, C.8
Connell-Crowley, L.9
Swindell, E.10
-
27
-
-
0036044835
-
The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression)
-
Sax J.K., Dash B.C., Hong R., Dicker D.T., El-Deiry W.S. The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression). Cell Cycle. 1:2002;90-96.
-
(2002)
Cell Cycle
, vol.1
, pp. 90-96
-
-
Sax, J.K.1
Dash, B.C.2
Hong, R.3
Dicker, D.T.4
El-Deiry, W.S.5
-
28
-
-
0034716993
-
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle
-
Zhu X., Hadhazy M., Wehling M., Tidball J.G., McNally E.M. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett. 474:2000;71-75.
-
(2000)
FEBS Lett.
, vol.474
, pp. 71-75
-
-
Zhu, X.1
Hadhazy, M.2
Wehling, M.3
Tidball, J.G.4
McNally, E.M.5
|